Translational Oncology Research Center

Activities

Activities per year 1974 2009 2010 2021 2022 2023 2024 2025

• 371 Participation in conference
• 273 Participation in workshop, seminar
• 228 Talk or presentation at a conference
• 124 Talk or presentation at a workshop/seminar
• 273 More
  • 44 Membership of external research organisation
  • 29 Publication peer-review
  • 27 Membership of peer-review panel or committee
  • 22 Membership of public/government advisory/policy group or panel
  • 20 Work on academic committees and working groups
  • 20 Talk at a public lecture/debate
  • 15 Participating in or organizing a public lecture/debate
  • 15 Research and Teaching at External Organisation
  • 15 Written proposal
  • 13 Participating in or organizing a school event
  • 12 Member of PhD committee
  • 12 Talk at an external academic organisation
  • 7 Editorial activity
  • 7 Other
  • 6 Participating in or organizing an event at an external academic organisation
  • 4 Talk at a school event
  • 3 Work on advisory panel to industry or government or non-government organisation
  • 1 Consultancy
  • 1 Work on advisory panels for social, community and cultural engagement

Activities per year

Search results

• Kom Op Tegen Kanker call for clinical studies proposal

  Bertels Cleo (Presenter)

  17 Jan 2025

  Activity: Other › Written proposal

• FWO predoctoral fellowship strategic basic research

  Bertels Cleo (Presenter)

  3 Mar 2025

  Activity: Other › Written proposal

• FWO - PhD Fellowship strategic basic research

  Gies Van Craesbeek (Contributor)

  3 Mar 2025

  Activity: Other › Written proposal

• Can Epigenetics Hold the Key to Explain Stress Intolerance and Chronic Pain in Breast Cancer Survivors?

  Arne Wyns (Contributor), Andrea Polli (Supervisor), Jo Nijs (Supervisor), Elke De Bruyne (Supervisor) & Lode Godderis (Participant)

  1 Mar 2024

  Activity: Other › Written proposal

• Interactions between pharmacokinetics of paclitaxel, physical activity and body composition in breast cancer. Search for starting points to reduce dose limiting toxicities

  Stephanie Wuyts (Contributor), Nele Adriaenssens (Supervisor), David Beckwée (Contributor), Steven Provyn (Contributor), Stephane Steurbaut (Contributor), Amy de Haar-Holleman (Contributor), Katrien Lanckmans (Contributor), Jan Van Bocxlaer (Contributor), An Vermeulen (Contributor), Elke Gasthuys (Contributor) & Sofie Vande Casteele (Contributor)

  24 Jan 2024

  Activity: Other › Written proposal

• FWO-PhD Fellowship fundamental research

  Rebeca De Wolf (Contributor)

  1 Mar 2024

  Activity: Other › Written proposal

• 2023 SITC-Merck Cancer Immunotherapy Clinical Fellowship

  Marthe Verhaert (Participant)

  14 Apr 2023

  Activity: Other › Written proposal

• Kom Op Tegen Kanker projectaanvraag

  Marthe Verhaert (Participant)

  14 Feb 2023

  Activity: Other › Written proposal

• 2023 SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship

  Marthe Verhaert (Participant)

  14 Apr 2023

  Activity: Other › Written proposal

• Investigating the clinical application and in vitro effect of regorafenib in advanced and metastatic melanoma and overcoming acquired resistance to targeted therapies.

  Iris Dirven (Presenter)

  27 Feb 2023

  Activity: Other › Written proposal

  File

• Can Epigenetics Hold the Key to Explain Stress Intolerance and Persistent Pain in Breast Cancer Survivors?

  Arne Wyns (Contributor), Andrea Polli (Supervisor), Jo Nijs (Supervisor), Elke De Bruyne (Supervisor) & Lode Godderis (Supervisor)

  1 Mar 2023

  Activity: Other › Written proposal

• FWO PhD fellowship strategic basic research

  Marthe Verhaert (Participant)

  28 Feb 2023

  Activity: Other › Written proposal

• Startersbeurs Kom Op Tegen Kanker

  Marthe Verhaert (Participant)

  13 Feb 2023

  Activity: Other › Written proposal

• Developing and deploying intratumoral cancer immunotherapy with AS01B combined with autologous myeloid dendritic cells and natural killer cells

  Manon Vounckx (Presenter)

  1 Jan 2023 → 1 Oct 2023

  Activity: Other › Written proposal

• FWO-SB fellowship: CARGO: advancing chimeric antigen receptor T cell therapy using nanobody-displaying lentiviral vectors.

  Fien Meeus (Participant) & Fien Meeus (Contributor)

  1 Nov 2020 → 31 Oct 2024

  Activity: Other › Written proposal